Highlight-Projekte

Highlight-Projekte von Beginn der Kooperation 1976 bis heute

 

Ca-No. Principal Investigators Project Title Running Period

 

Ca 169 D. Ginsberg, Bar-Ilan University ./. I. Grummt, DKFZ

A novel mode of non-coding RNA in gene regulation: An E2F1-dependent antisense RNA activates expression of the proto-oncogene SPHK

01.07.2015 - 30.06.2018

 

Ca 160 R. Beck-Barkai, Tel Aviv University, B. Geiger, Weizmann Institute ./. E. Gladilin, DKFZ

Dissecting the contribution of vimentin intermediate filaments to mechanical and structural properties of cancer cells, using advanced physical approaches

01.07.2014 - 30.06.2017

 

Ca 159 C. Levy, Tel Aviv University ./. J. Hoheisel, DKFZ

Exploring microRNA transfer and melanoma progression: novel concept of cell-cell communication in the tumor microenvironment

01.07.13 – 30.06.16

 

Ca 149 Y. Ben-Neriah, Hebrew University ./. H. Allgayer, DKFZ

microRNA control of tissue invasion and intestinal cancer 

01.07.11 – 30.06.14

 

Ca 147 E. Pikarsky, Hebrew University ./. P. Angel, DKFZ

Cross species inflammatory oncogenomics to identify therapeutic targets for liver cancer

01.07.11 – 30.06.14

 

Ca 120 Y. Shiloh, Tel Aviv University ./. W.Lehmann (div. of W.E. Hull), DKFZ

Identification and functional analysis of protein phosphorylationand dephosphorylation in the ATM-mediated DNA damage response

01.07.05 – 30.06.08

 

Ca 092 O. Mandelboim, Hebrew University / F.Momburg (G. Hämmerling), DKFZ

Identification of NKp46 ligand: A ligand which is involved in thelysis of tumor cells and virally infected cells by natural killer cells

01.01.01 – 31.12.03

 

Ca 086 M. Oren, Weizmann Inst. / P. Krammer,DKFZ

The role of p53 in drug-induced apoptosis 

01.07.99 – 30.06.02

 

Ca 081 A. Ciechanover, Technion / M. Scheffner(E.M. de Villiers)

Regulation of cell regulatory proteins by the ubiquitin-dependentproteolytic pathway

01.01.98 – 31.12.00

 

Ca 059 A. Kimchi, Weizmann Inst. / N. E.Fusenig, DKFZ

Negative regulating growth factors and the significance of theirabrogation in carcinogenesis

01.07.93 – 30.06.96

 

Ca 058 E. Keshet, Hebrew Univ. Hadassah Med.School / E. Spiess, DKFZ

Regulation of proteases and their respective inhibitors mediatingcell invasiveness during angiogenesis and metastasis

01.07.93 – 30.06.96

 

Ca 051 M. Oren, Weizmann Inst. / R. Corvi (M.Schwab), DKFZ

Analysis of tumor suppressor genes in human cancers 

01.01.92 – 31.12.94

 

Ca 050 M. Aboud, Ben Gurion Univ. / M. Löchelt(R. Flügel), DKFZ

Tumorigenic cooperation between human retroviruses, onco-genes and other carcinogens

01.01.92 – 31.12.94

 

Ca 049 B. Geiger, Weizmann Inst. / M. Schmelz(W.Franke), DKFZ

Structure-function relationships in adhering cell junctions ofnormal and transformed cells

01.07.90 – 30.06.93

 

Ca 041 D. Wallach, Weizmann Inst. / H.Holtmann, Med. Hochschule Hannover,D. Männel (W. Dröge), DKFZ

Mechanisms controlling the response to tumor necrosis factor 

01.01.89 – 31.12.91

 

Ca 024 I. Vlodavsky, Hadassah Univ. Hospital /V. Schirrmacher, DKFZ

Interaction of metastasizing and non-metastasizing tumors with cultured vascular endothelial cells and their underlying lamina

01.01.83 – 31.12.85

 

Formular

Formulardaten werden geladen ...